galmedpharma.investorroom.comGalmed Pharmaceuticals Investors Center
galmedpharma.investorroom.com Profile
Galmedpharma.investorroom.com is a subdomain of Investorroom.com,
which was created on 2000-02-13,making it 24 years ago.
It has several subdomains, such as eqbank.investorroom.com
uti.investorroom.com , among others.
Description：Stay informed with Galmed Pharmaceuticals' latest news, events, presentations, SEC filings, stock information, corporate governance, and investor contact details in the Investors Center....
Keywords：Galmed Pharmaceuticals, investors, news, events, presentations, SEC filings, stock information, corporate governance, investor contact....
Discover galmedpharma.investorroom.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
galmedpharma.investorroom.com Information
| HomePage size: 95.065 KB |
| Page Load Time: 0.375783 Seconds |
| Website IP Address: 104.17.204.159 |
galmedpharma.investorroom.com Similar Website
| Maryland Real Estate Investors Association - Maryland Real Estate Investors Association |
| Western Midstream - Investors - Investors |
| OMNOVA Solutions - Investors - Investors |
| Investors :: Conatus Pharmaceuticals Inc. (CNAT) |
| Eagle Pharmaceuticals Investor Center | |
| Investors | Marathon Oil Corporation - Investors |
| Investment Research - Stock Quotes, Stock Tips, Options Center - IBD - Investors.com |
| Axalta Coating Systems - Investors - Investors Overview |
| Investors & Media | Ionis Pharmaceuticals, Inc. |
| Inovio Pharmaceuticals, Inc. - INVESTORS & MEDIA |
| Investors | Syndax Pharmaceuticals, Inc. |
| Connected Investors | Connect With Real Estate Investors |
| Investors | Fusion Pharmaceuticals - Overview |
| Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
| Investors - Toromont Industries Ltd. - Investors |
galmedpharma.investorroom.com PopUrls
| Investors Center https://galmedpharma.investorroom.com/ |
| Events & Presentations - Galmed Pharmaceuticals https://galmedpharma.investorroom.com/events |
| Investor FAQs - Galmed Pharmaceuticals https://galmedpharma.investorroom.com/faqs |
| SEC Filings - Galmed Pharmaceuticals https://galmedpharma.investorroom.com/sec-filings |
| Press Releases - Galmed Pharmaceuticals https://galmedpharma.investorroom.com/press-releases |
| Corporate Governance - Galmed Pharmaceuticals https://galmedpharma.investorroom.com/corporate-governance |
| Get Alerts - Galmed Pharmaceuticals https://galmedpharma.investorroom.com/email-alerts |
| Galmed Pharmaceuticals - Investor Contact https://galmedpharma.investorroom.com/investor-contact |
| Stock Info - Galmed Pharmaceuticals https://galmedpharma.investorroom.com/stock-info |
galmedpharma.investorroom.com Httpheader
| Date: Sat, 11 May 2024 09:38:31 GMT |
| Content-Type: text/html; charset=UTF-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Cache-Control: public, no-cache |
| Vary: Accept-Encoding |
| CF-Cache-Status: EXPIRED |
| Last-Modified: Sat, 11 May 2024 08:12:44 GMT |
| Server: cloudflare |
| CF-RAY: 8821324ed9481664-SJC |
galmedpharma.investorroom.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-Type"/ |
| content="" name="keywords" |
| content="" name="description"/ |
| content="summary" name="twitter:card"/ |
| content="Galmed Pharmaceuticals" property="og:site_name"/ |
| content="https://galmedpharma.investorroom.com/welcome" property="og:url"/ |
| content="IE=edge" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="max-image-preview:large" name="robots"/ |
galmedpharma.investorroom.com Html To Plain Text
People Pipeline News Investors Contact ARMOR Phase 3 Study Investors Home We’re proud of our unique multi-generational leadership matrix that brings together both innovative younger minds and experienced long-term industry leadersInvestors Home Press Releases EventsPresentations SEC Filings Stock Info Corporate Governance Get Alerts Investor Contact Overview Investors Home Press Releases EventsPresentations SEC Filings Stock Info Corporate Governance Get Alerts Investor Contact Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also developing Amilo-5MER, a 5 amino acid synthetic peptide and recently initiated a first in human study. Stock Snapshot NASDAQ GLMD Corporate Presentation Download NASDAQ GLMD 5d 1m 3m 6m YTD 1y 5y 10y Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Loading... Display Events Dividends Splits Earnings News Chart Style Line Mountain OHLC Candlestick Currency in USD. Quote data delayed by at least 15 minutes. Earnings Events data provided by Wall Street Horizon. Get Alerts Press Releases Apr 4, 2024 Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023 Mar 15, 2024 Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis Nov 20, 2023 Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study All Press Releases » © Galmed Pharmaceuticals | All Rights Reserved. Term of Use Privacy Policy Privacy Notice for California Residents Privacy Rights Policy Data Subjects Request Form Study Subjects Disclaimer BrandingWebsite...
galmedpharma.investorroom.com Whois
Domain Name: INVESTORROOM.COM Registry Domain ID: 19764015_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2024-02-09T06:12:35Z Creation Date: 2000-02-13T16:35:21Z Registry Expiry Date: 2025-02-13T16:35:21Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DOM.NS.CLOUDFLARE.COM Name Server: MIA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T12:50:47Z <<<